J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 71 (1990), 2425-2431; DOI 10.1099/0022-1317-71-10-2425
© 1990 Society for General Microbiology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eloit, M.
Right arrow Articles by Perricaudet, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eloit, M.
Right arrow Articles by Perricaudet, M.
Agricola
Right arrow Articles by Eloit, M.
Right arrow Articles by Perricaudet, M.

Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine

M. Eloit1, P. Gilardi-Hebenstreit2, B. Toma1 and M. Perricaudet2

1 Laboratoire d'Épidémiologie et de Physiopathologie des Maladies Animales à Virus, INRA, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons-Alfort
and2 Institut Gustave Roussy, CNRS, UA 1301, 94800 Villejuif, France

The gene encoding the pseudorabies virus glycoprotein gp50 was cloned at the very left end of the genome of adenovirus type 5 to give a recombinant adenovirus (Ad-gp50) defective for the E1A gene. Ad-gp50 expressed high levels of gp50 in cells which either complemented (293 cells) or did not complement (Vero and HeLa cells) the E1A gene. Surprisingly, over an extended period, higher levels of gp50 were produced in HeLa cells which lack the E1A gene. Rabbits and mice inoculated with Ad-gp50 showed a strong antibody response against gp50. Some of them were protected from a virulent challenge with pseudorabies virus.

Received 17 April 1990; accepted 6 June 1990.


This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
M. J. Grubman and B. Baxt
Foot-and-Mouth Disease
Clin. Microbiol. Rev., April 1, 2004; 17(2): 465 - 493.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. Branger, C. Sonrier, B. Chatrenet, B. Klonjkowski, N. Ruvoen-Clouet, A. Aubert, G. Andre-Fontaine, and M. Eloit
Identification of the Hemolysis-Associated Protein 1 as a Cross-Protective Immunogen of Leptospira interrogans by Adenovirus-Mediated Vaccination
Infect. Immun., November 1, 2001; 69(11): 6831 - 6838.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. M. Timmerman, C. B. Caspar, S. L. Lambert, A. D. Syrengelas, and R. Levy
Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomas
Blood, March 1, 2001; 97(5): 1370 - 1377.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X. J. Da Costa, C. A. Jones, and D. M. Knipe
Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection
PNAS, June 8, 1999; 96(12): 6994 - 6998.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1990 by the Society for General Microbiology.